{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:45:10Z","timestamp":1791279910676,"version":"4.1.0"},"reference-count":200,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.dld.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T10:13:58Z","timestamp":1439547238000},"page":"997-1006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":388,"title":["Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups"],"prefix":"10.1016","volume":"47","author":[{"given":"Amedeo","family":"Lonardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bellentani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis K.","family":"Argo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ballestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cortez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana V.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2015.08.004_bib1000","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000323886","article-title":"ASH and NASH","volume":"29","author":"Scaglioni","year":"2011","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.dld.2015.08.004_bib1005","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0029-1222606","article-title":"Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome","volume":"35","author":"Targher","year":"2009","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1016\/j.dld.2015.08.004_bib1015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1586\/17474124.2014.903798","article-title":"Management of fatty liver disease with the metabolic syndrome","volume":"8","author":"Machado","year":"2014","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2015.08.004_bib1030","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.2174\/1381612811319290003","article-title":"Cardiovascular and systemic risk in nonalcoholic fatty liver disease \u2013 atherosclerosis as a major player in the natural course of NAFLD","volume":"19","author":"Lonardo","year":"2013","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.dld.2015.08.004_bib1035","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/ATVBAHA.114.303034","article-title":"Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease","volume":"34","author":"Byrne","year":"2014","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.dld.2015.08.004_bib1040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2007.10.024","article-title":"Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation","volume":"134","author":"Baumeister","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cld.2009.07.005","article-title":"Epidemiology and natural history of non-alcoholic steatohepatitis","volume":"13","author":"Argo","year":"2009","journal-title":"Clinics in Liver Disease"},{"key":"10.1016\/j.dld.2015.08.004_bib1050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Annals of Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1055","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","article-title":"From NAFLD in clinical practice to answers from guidelines","volume":"59","author":"Nascimbeni","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000016909","article-title":"Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going?","volume":"17","author":"Lonardo","year":"1999","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.dld.2015.08.004_bib1065","doi-asserted-by":"crossref","first-page":"12956","DOI":"10.3748\/wjg.v20.i36.12956","article-title":"Non-alcoholic fatty liver disease: what the clinician needs to know","volume":"20","author":"Machado","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.dld.2010.01.021","article-title":"Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee","volume":"42","author":"Loria","year":"2010","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2015.08.004_bib1075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","article-title":"Prevalence of and risk factors for fatty liver in a general population of Shanghai, China","volume":"43","author":"Fan","year":"2005","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1080","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.3748\/wjg.v12.i36.5826","article-title":"Fatty liver, carotid disease and gallstones: a study of age-related associations","volume":"12","author":"Lonardo","year":"2006","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-230X-12-123","article-title":"Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units","volume":"12","author":"Hu","year":"2012","journal-title":"BMC Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1090","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study","volume":"47","author":"Eguchi","year":"2012","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1095","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/MEG.0000000000000151","article-title":"Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China","volume":"26","author":"Wang","year":"2014","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2007.02.007","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center","volume":"47","author":"Lee","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1105","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.3748\/wjg.v13.i47.6419","article-title":"Prevalence of fatty liver disease and its risk factors in the population of South China","volume":"13","author":"Zhou","year":"2007","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","article-title":"Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain","volume":"22","author":"Caballeria","year":"2010","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1115","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3748\/wjg.v9.i5.1106","article-title":"Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey","volume":"9","author":"Shen","year":"2003","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1120","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1478-3231.2006.01311.x","article-title":"Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures","volume":"26","author":"Zelber-Sagi","year":"2006","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2015.08.004_bib1125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","article-title":"Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.08.004_bib1130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00004836-200609000-00016","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults","volume":"40","author":"Chen","year":"2006","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1135","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s10620-013-2652-7","article-title":"The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA)","volume":"58","author":"Foster","year":"2013","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2015.08.004_bib1140","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/ajg.2013.104","article-title":"Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study","volume":"108","author":"Xu","year":"2013","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MEG.0b013e328365c403","article-title":"High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease","volume":"26","author":"Yang","year":"2014","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1155","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.exger.2013.05.059","article-title":"Prevalence and associated metabolic factors of fatty liver disease in the elderly","volume":"48","author":"Wang","year":"2013","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.dld.2015.08.004_bib1160","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jhep.2012.07.028","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study","volume":"57","author":"Koehler","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1170","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1159\/000235677","article-title":"Non-alcoholic fatty liver disease in older people","volume":"55","author":"Frith","year":"2009","journal-title":"Gerontology"},{"key":"10.1016\/j.dld.2015.08.004_bib1175","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/hep.26465","article-title":"Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1180","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s10620-007-0074-0","article-title":"Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis","volume":"53","author":"Singh","year":"2008","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2015.08.004_bib1185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.24726","article-title":"Ethnicity and nonalcoholic fatty liver disease","volume":"55","author":"Bambha","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/gastro\/gou034","article-title":"Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease","volume":"2","author":"Tapper","year":"2014","journal-title":"Gastroenterology Reports"},{"key":"10.1016\/j.dld.2015.08.004_bib1195","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","article-title":"Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Hossain","year":"2009","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"Argo","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1205","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1210","doi-asserted-by":"crossref","first-page":"14185","DOI":"10.3748\/wjg.v20.i39.14185","article-title":"Nonalcoholic fatty liver disease and aging: epidemiology to management","volume":"20","author":"Bertolotti","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1220","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1225","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1230","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s10620-013-2743-5","article-title":"Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"58","author":"Stepanova","year":"2013","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2015.08.004_bib1235","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.21827","article-title":"Incidence and natural course of fatty liver in the general population: the Dionysos study","volume":"46","author":"Bedogni","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1240","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/hep.23135","article-title":"Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels","volume":"50","author":"Haring","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1245","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1250","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.20554","article-title":"Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease","volume":"41","author":"Weston","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"178","author":"Lazo","year":"2013","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.dld.2015.08.004_bib1260","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.mayocp.2013.12.015","article-title":"Ethnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis","volume":"89","author":"Tota-Maharaj","year":"2014","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.dld.2015.08.004_bib1265","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ajg.2008.12","article-title":"The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients","volume":"104","author":"Kallwitz","year":"2009","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1270","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.2174\/13816128113199990381","article-title":"Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.dld.2015.08.004_bib1275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9343(99)00315-0","article-title":"Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds","volume":"108","author":"Struben","year":"2000","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1280","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/j.1572-0241.2001.04667.x","article-title":"Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease","volume":"96","author":"Willner","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1285","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2169\/internalmedicine.47.0476","article-title":"Familial aggregation in patients with non-alcoholic steatohepatitis","volume":"47","author":"Tokushige","year":"2008","journal-title":"Internal Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1290","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1194\/jlr.M600312-JLR200","article-title":"Heritability and genetic loci of fatty liver in familial combined hyperlipidemia","volume":"47","author":"Brouwers","year":"2006","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.dld.2015.08.004_bib1295","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.cgh.2006.06.001","article-title":"Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease","volume":"4","author":"Abdelmalek","year":"2006","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1300","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1053\/j.gastro.2009.01.050","article-title":"Heritability of nonalcoholic fatty liver disease","volume":"136","author":"Schwimmer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/clinchem\/47.1.81","article-title":"Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study","volume":"47","author":"Bathum","year":"2001","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.dld.2015.08.004_bib1310","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2008.12.025","article-title":"Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins","volume":"50","author":"Makkonen","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1315","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1053\/j.gastro.2010.06.009","article-title":"Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins","volume":"139","author":"Loomba","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1320","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1475-2840-10-96","article-title":"Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study","volume":"10","author":"Jermendy","year":"2011","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.dld.2015.08.004_bib1325","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1478-3231.2012.02823.x","article-title":"Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study","volume":"32","author":"Tarnoki","year":"2012","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2015.08.004_bib1330","article-title":"Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study","author":"Zarrinpar","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.08.004_bib1335","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2013.476","article-title":"The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis","volume":"109","author":"Singal","year":"2014","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1340","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1194\/jlr.P900013-JLR200","article-title":"A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity","volume":"50","author":"Sookoian","year":"2009","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.dld.2015.08.004_bib1345","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.23768","article-title":"PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease","volume":"52","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1350","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1355","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1360","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23823","article-title":"I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease","volume":"52","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1365","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver","volume":"18","author":"Beer","year":"2009","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.dld.2015.08.004_bib1370","doi-asserted-by":"crossref","first-page":"e87523","DOI":"10.1371\/journal.pone.0087523","article-title":"Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease","volume":"9","author":"Petta","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.dld.2015.08.004_bib1375","doi-asserted-by":"crossref","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLOS Genetics"},{"key":"10.1016\/j.dld.2015.08.004_bib1380","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000346195","article-title":"Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity","volume":"75","author":"Gorden","year":"2013","journal-title":"Human Heredity"},{"key":"10.1016\/j.dld.2015.08.004_bib1385","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/MPG.0000000000000279","article-title":"A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease","volume":"58","author":"Nobili","year":"2014","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1016\/j.dld.2015.08.004_bib1390","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jhep.2012.01.007","article-title":"IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease","volume":"56","author":"Petta","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1395","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.04.004","article-title":"The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease","volume":"135","author":"Miele","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1400","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.27556","article-title":"Genetic variation in TM6SF2 and the risk of nonalcoholic fatty liver disease and histological disease severity","volume":"61","author":"Sookoian","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1405","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2337\/db08-0422","article-title":"Evaluating the role of LPIN1 variation in insulin resistance, body weight, and human lipodystrophy in UK populations","volume":"57","author":"Fawcett","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.dld.2015.08.004_bib1410","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MPG.0b013e3182442a55","article-title":"LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease","volume":"54","author":"Valenti","year":"2012","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1016\/j.dld.2015.08.004_bib1415","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.dld.2015.08.004_bib1420","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.dld.2015.08.004_bib1425","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.dld.2015.08.004_bib1430","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20080253","article-title":"Metabolic disturbances in non-alcoholic fatty liver disease","volume":"116","author":"Byrne","year":"2009","journal-title":"Clinical Science (London)"},{"key":"10.1016\/j.dld.2015.08.004_bib1435","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1464-5491.2012.03732.x","article-title":"Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management","volume":"29","author":"Byrne","year":"2012","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1440","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"Targher","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.dld.2015.08.004_bib1445","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1450","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs. non-alcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1455","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2014.01.009","article-title":"Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension","volume":"60","author":"Sung","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1460","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jgh.12643","article-title":"Clinical association between non-alcoholic fatty liver disease and the development of hypertension","volume":"29","author":"Ryoo","year":"2014","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1465","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1440-1746.2005.03924.x","article-title":"Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors","volume":"20","author":"Loria","year":"2005","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1470","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.0000248752.08807.4c","article-title":"Uric acid and the development of hypertension: the normative aging study","volume":"48","author":"Perlstein","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.dld.2015.08.004_bib1475","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/hep.23717","article-title":"Association between serum uric acid level and chronic liver disease in the United States","volume":"52","author":"Afzali","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1480","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.amjcard.2012.08.012","article-title":"Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis","volume":"110","author":"Keenan","year":"2012","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.dld.2015.08.004_bib1485","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1476-511X-13-117","article-title":"Associations of non-high density lipoprotein cholesterol and traditional blood lipid profiles with hyperuricemia among middle-aged and elderly Chinese people: a community-based cross-sectional study","volume":"13","author":"Xu","year":"2014","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.dld.2015.08.004_bib1490","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1590-8658(02)80194-3","article-title":"Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case\u2013control study","volume":"34","author":"Lonardo","year":"2002","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2015.08.004_bib1495","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/03009741003742797","article-title":"Gout and risk of non-alcoholic fatty liver disease","volume":"39","author":"Kuo","year":"2010","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1500","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3346\/jkms.2011.26.3.386","article-title":"The relationship between normal serum uric acid and nonalcoholic fatty liver disease","volume":"26","author":"Hwang","year":"2011","journal-title":"Journal of Korean Medical Science"},{"key":"10.1016\/j.dld.2015.08.004_bib1505","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2011.04788.x","article-title":"Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease","volume":"34","author":"Petta","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.08.004_bib1510","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.metabol.2010.08.005","article-title":"Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men","volume":"60","author":"Ryu","year":"2011","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.1016\/j.dld.2015.08.004_bib1515","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MPG.0b013e318229da1a","article-title":"Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD","volume":"54","author":"Vos","year":"2012","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1016\/j.dld.2015.08.004_bib1520","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.metabol.2012.08.013","article-title":"Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey","volume":"62","author":"Sirota","year":"2013","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.1016\/j.dld.2015.08.004_bib1525","doi-asserted-by":"crossref","first-page":"e11578","DOI":"10.1371\/journal.pone.0011578","article-title":"High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study","volume":"5","author":"Xu","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2015.08.004_bib1530","doi-asserted-by":"crossref","first-page":"e67152","DOI":"10.1371\/journal.pone.0067152","article-title":"Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2015.08.004_bib1535","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/jc.2007-0482","article-title":"Liver fat in the metabolic syndrome","volume":"92","author":"Kotronen","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.dld.2015.08.004_bib1540","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2337\/dc07-1463","article-title":"Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects","volume":"31","author":"Kotronen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2015.08.004_bib1545","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2337\/diabetes.49.5.749","article-title":"Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients","volume":"49","author":"Ryysy","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.dld.2015.08.004_bib1550","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1555","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.dld.2015.08.004_bib1560","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1565","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2337\/diacare.22.5.756","article-title":"Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study","volume":"22","author":"de Marco","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2015.08.004_bib1570","doi-asserted-by":"crossref","first-page":"E526","DOI":"10.1503\/cmaj.092144","article-title":"Newly diagnosed diabetes mellitus as a risk factor for serious liver disease","volume":"182","author":"Porepa","year":"2010","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.dld.2015.08.004_bib1575","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/dc12-0002","article-title":"Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults","volume":"35","author":"Campbell","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2015.08.004_bib1580","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ajg.2014.132","article-title":"Mortality from chronic liver diseases in diabetes","volume":"109","author":"Zoppini","year":"2014","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1585","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2010.18","article-title":"Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study","volume":"105","author":"Adams","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1590","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2015.08.004_bib1595","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1600","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.dld.2015.08.004_bib1605","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.dld.2015.08.004_bib1610","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1681\/ASN.2007101155","article-title":"Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease","volume":"19","author":"Targher","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.dld.2015.08.004_bib1615","series-title":"Obesity and overweight","author":"Centre WHOM","year":"2013"},{"key":"10.1016\/j.dld.2015.08.004_bib1620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2009.12.014","article-title":"The epidemiology of obesity","volume":"39","author":"Nguyen","year":"2010","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1016\/j.dld.2015.08.004_bib1625","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000126822","article-title":"Management of obesity in adults: European clinical practice guidelines","volume":"1","author":"Tsigos","year":"2008","journal-title":"Obesity Facts"},{"key":"10.1016\/j.dld.2015.08.004_bib1630","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1001\/archinte.163.18.2146","article-title":"Increases in clinically severe obesity in the United States, 1986\u20132000","volume":"163","author":"Sturm","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1635","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1640","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0168-8278(01)00151-9","article-title":"The spectrum of liver disease in the general population: lesson from the Dionysos study","volume":"35","author":"Bellentani","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1645","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1650","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.08.004_bib1655","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1660","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2011.12.011","article-title":"Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up","volume":"56","author":"Zelber-Sagi","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1665","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11695-011-0438-6","article-title":"Clinical predictors of different grades of nonalcoholic fatty liver disease","volume":"22","author":"Junior","year":"2012","journal-title":"Obesity Surgery"},{"key":"10.1016\/j.dld.2015.08.004_bib1670","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1675","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1680","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1152\/ajpendo.00203.2004","article-title":"Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance","volume":"288","author":"Kabir","year":"2005","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.dld.2015.08.004_bib1685","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1055\/s-2002-38256","article-title":"Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome","volume":"34","author":"Wajchenberg","year":"2002","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.dld.2015.08.004_bib1690","doi-asserted-by":"crossref","first-page":"154672","DOI":"10.1155\/2011\/154672","article-title":"Visceral abdominal and subfascial femoral adipose tissue have opposite associations with liver fat in overweight and obese premenopausal Caucasian women","volume":"2011","author":"Rocha","year":"2011","journal-title":"Journal of Lipids"},{"key":"10.1016\/j.dld.2015.08.004_bib1695","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.26072","article-title":"Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause","volume":"57","author":"van der Poorten","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1700","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4254\/wjh.v6.i5.263","article-title":"Obesity and non-alcoholic fatty liver disease: disparate associations among Asian populations","volume":"6","author":"Wong","year":"2014","journal-title":"World Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1705","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MEG.0b013e3283513f19","article-title":"Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease","volume":"24","author":"Colak","year":"2012","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1710","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/oby.20624","article-title":"Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects","volume":"22","author":"Iacobellis","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.dld.2015.08.004_bib1715","first-page":"e001979","article-title":"Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease","volume":"8","author":"Gran\u00e9r","year":"2014","journal-title":"Circulation: Cardiovascular Imaging"},{"key":"10.1016\/j.dld.2015.08.004_bib1720","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","article-title":"Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1725","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/hep.21803","article-title":"The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome","volume":"46","author":"Cheung","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1730","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2015.01.008","article-title":"Epicardial fat and liver disease; the contribution of cardio autonomic nervous system function","volume":"62","author":"Ulucan","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1735","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/ajg.2012.320","article-title":"Non-alcoholic fatty liver disease and obesity: not all about body mass index","volume":"107","author":"Pagadala","year":"2012","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1740","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MOL.0b013e3283346ccc","article-title":"The distinction of metabolically \u2018healthy\u2019 from \u2018unhealthy\u2019 obese individuals","volume":"21","author":"Bluher","year":"2010","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.dld.2015.08.004_bib1745","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/dc12-1654","article-title":"Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter","volume":"36","author":"Hinnouho","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2015.08.004_bib1750","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","article-title":"The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"163","author":"Park","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1755","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Consultation","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2015.08.004_bib1760","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diabetes.47.5.699","article-title":"The metabolically obese, normal-weight individual revisited","volume":"47","author":"Ruderman","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.dld.2015.08.004_bib1765","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2009.06.020","article-title":"Metabolically healthy but obese individuals: relationship with hepatic enzymes","volume":"59","author":"Messier","year":"2010","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.1016\/j.dld.2015.08.004_bib1770","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2013.04.016","article-title":"Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance","volume":"59","author":"Thelwall","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1775","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency \u2013 an under-recognized cause of dyslipidaemia and liver dysfunction","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dld.2015.08.004_bib1780","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep.26289","article-title":"Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease","volume":"58","author":"Balwani","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1785","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2014.06.022","article-title":"Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency","volume":"61","author":"Valayannopoulos","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1790","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","article-title":"Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension","volume":"19","author":"Fallo","year":"2009","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"},{"key":"10.1016\/j.dld.2015.08.004_bib1795","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7150\/ijms.8.254","article-title":"Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China","volume":"8","author":"Zhang","year":"2011","journal-title":"International Journal of Medical Sciences"},{"key":"10.1016\/j.dld.2015.08.004_bib1800","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1440-1746.2010.06509.x","article-title":"Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese","volume":"26","author":"Hou","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1805","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.3748\/wjg.v19.i32.5334","article-title":"Prevalence and features of fatty liver detected by physical examination in Guangzhou","volume":"19","author":"Liao","year":"2013","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1810","first-page":"351","article-title":"The \u2018bright liver\u2019 syndrome. Prevalence and determinants of a bright liver echo pattern","volume":"29","author":"Lonardo","year":"1997","journal-title":"Italian Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1815","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/liv.12743","article-title":"Effect of enforced physical inactivity induced by 60-d of bed rest on hepatic markers of NAFLD in healthy normal-weight women","volume":"35","author":"Rudwill","year":"2015","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2015.08.004_bib1820","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3109\/00365521.2011.560679","article-title":"Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men","volume":"46","author":"Schult","year":"2011","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1825","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1194\/jlr.P054387","article-title":"Lipoprotein subclass metabolism in nonalcoholic steatohepatitis","volume":"55","author":"M\u00e4nnist\u00f6","year":"2014","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.dld.2015.08.004_bib1830","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cgh.2012.01.017","article-title":"Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis","volume":"10","author":"Corey","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1835","article-title":"Severity of nonalcoholic fatty liver disease and progression to cirrhosis associate with atherogenic lipoprotein profile","volume":"13","author":"Siddiqui","year":"2014","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1840","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","article-title":"The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study","volume":"54","author":"Bhala","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1845","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2013.10.030","article-title":"Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology","volume":"232","author":"Loria","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dld.2015.08.004_bib1850","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11886-012-0313-7","article-title":"Dyslipidemias in the prevention of cardiovascular disease: risks and causality","volume":"14","author":"Graham","year":"2012","journal-title":"Current Cardiology Reports"},{"key":"10.1016\/j.dld.2015.08.004_bib1855","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/17474124.2015.965143","article-title":"Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease","volume":"9","author":"Lonardo","year":"2015","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1860","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(96)70082-3","article-title":"Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B","volume":"111","author":"Tarugi","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1865","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2005.06.018","article-title":"Hepatic steatosis and insulin resistance: does etiology make a difference","volume":"44","author":"Lonardo","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1870","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhep.2014.05.023","article-title":"Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia","volume":"61","author":"Di Filippo","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1875","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1880","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1885","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s10620-014-3380-3","article-title":"Total body weight loss of \u226510% is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis","volume":"60","author":"Glass","year":"2015","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2015.08.004_bib1890","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","article-title":"Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"57","author":"Keating","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1895","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.clinre.2012.10.009","article-title":"Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"37","author":"Scaglioni","year":"2013","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1900","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.2337\/dc13-0102","article-title":"Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss","volume":"36","author":"Haufe","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2015.08.004_bib1905","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1910","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/egh.11.19","article-title":"Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies","volume":"5","author":"Lonardo","year":"2011","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1915","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.2337\/dc10-0856","article-title":"Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes","volume":"33","author":"Lazo","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2015.08.004_bib1920","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hep.26393","article-title":"Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial)","volume":"58","author":"Bacchi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1925","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2015.08.004_bib1930","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1185\/030079908X253870","article-title":"Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years","volume":"24","author":"Klonoff","year":"2008","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.dld.2015.08.004_bib1935","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/liv.12611","article-title":"Renin\u2013angiotensin system and fibrosis in non-alcoholic fatty liver disease","volume":"35","author":"Goh","year":"2015","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2015.08.004_bib1940","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis","volume":"40","author":"Yokohama","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1945","first-page":"39","article-title":"Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study","volume":"16","author":"Georgescu","year":"2007","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"key":"10.1016\/j.dld.2015.08.004_bib1950","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3748\/wjg.15.942","article-title":"Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis","volume":"15","author":"Georgescu","year":"2009","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1955","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.27289","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids in non-alcoholic fatty liver disease: results from the *WELCOME study","volume":"60","author":"Scorletti","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1960","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","article-title":"Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial","volume":"62","author":"Argo","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.08.004_bib1965","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"Sanyal","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1970","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"1","author":"Taylor","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.dld.2015.08.004_bib1975","first-page":"CD008623","article-title":"Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"12","author":"Eslami","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.dld.2015.08.004_bib1980","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00535-010-0291-8","article-title":"Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease","volume":"46","author":"Park","year":"2011","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.08.004_bib1985","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00125-013-3149-9","article-title":"The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial","volume":"57","author":"Takeshita","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.dld.2015.08.004_bib1990","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2015.08.004_bib1995","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"Journal of Hepatology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581500568X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581500568X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T05:53:45Z","timestamp":1599458025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086581500568X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":200,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S159086581500568X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2015.08.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}